Northern Biologics Inc., a developer of first‐in‐class immuno‐oncology products, announced Philip Vickers, Ph.D., formerly of global head of R&D for Shire, will be joining the company as CEO and a member of the board. Stefan Larson, Ph.D., who served as Northern Biologics’ founding CEO since 2014, will remain on the company’s board.
Read the full release here.